Review



timer 2 0  (Human Protein Atlas)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Human Protein Atlas timer 2 0
    The expression of USP22 in various malignancies and the corresponding normal tissues was obtained using Timer 2.0. ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; COAD, colon adenocarcinoma; DLBC, lymphoid neoplasm diffuse large B‐cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LAML, acute myeloid leukemia; LGG, brain lower grade glioma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumors; THCA, thyroid carcinoma; THYM, thymoma; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma. The number of stars represents the statistical significance as determined by the Wilcoxon test (** p < 0.01, and *** p < 0.001).
    Timer 2 0, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/timer/0+2+timer/pmc13171463-30-6-1
    Average 86 stars, based on 1 article reviews
    timer 2 0 - by Bioz Stars, 2026-09
    86/100 stars

    Images

    1) Product Images from "Decoding the Oncogenic Role of USP22 Through Pan‐Cancer Genomic and Epigenetic Analysis"

    Article Title: Decoding the Oncogenic Role of USP22 Through Pan‐Cancer Genomic and Epigenetic Analysis

    Journal: Cancer Reports

    doi: 10.1002/cnr2.70572

    The expression of USP22 in various malignancies and the corresponding normal tissues was obtained using Timer 2.0. ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; COAD, colon adenocarcinoma; DLBC, lymphoid neoplasm diffuse large B‐cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LAML, acute myeloid leukemia; LGG, brain lower grade glioma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumors; THCA, thyroid carcinoma; THYM, thymoma; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma. The number of stars represents the statistical significance as determined by the Wilcoxon test (** p < 0.01, and *** p < 0.001).
    Figure Legend Snippet: The expression of USP22 in various malignancies and the corresponding normal tissues was obtained using Timer 2.0. ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; COAD, colon adenocarcinoma; DLBC, lymphoid neoplasm diffuse large B‐cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LAML, acute myeloid leukemia; LGG, brain lower grade glioma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumors; THCA, thyroid carcinoma; THYM, thymoma; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma. The number of stars represents the statistical significance as determined by the Wilcoxon test (** p < 0.01, and *** p < 0.001).

    Techniques Used: Expressing

    Related Articles

    other:

    Article Title: Multi-omics pan-cancer analysis reveals the diagnostic and prognostic value of C8orf76, with experimental validation of its impact on lung adenocarcinoma cell proliferation
    Article Snippet: Multi-omics pan-cancer analysis by utilizing datasets including UALCAN, TIMER 2.0, Human Protein Atlas (HPA), The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), cBioPortal, Gene Expression Profiling Interactive Analysis (GEPIA), OncoDB, and MethSurv datasets, were conducted to analyze C8orf76 across 33 cancer types.

    Article Title: Preliminary study on the role of the C5orf46 gene in renal cancer.
    Article Snippet: TIMER 2.0 [16](http://timer.cistrome.org/), TCGA(http://tcga-data .nci.nih.gov/tcga), Gene Expression Omnibus (GEO)(https://www.ncbi. nlm.nih.gov/gds/) and Human Protein Atlas (HPA) database [17] (https://www.proteinatlas.org/) were used to obtain C5orf46 expression at the transcriptional and protein levels in renal cancer.

    Expressing:

    Article Title: Decoding the Oncogenic Role of USP22 Through Pan‐Cancer Genomic and Epigenetic Analysis
    Article Snippet: .. The Human Protein Atlas, UALCAN, and Timer 2.0 were used to examine USP22 expression at the gene and protein levels in 33 TCGA cancer types. ..

    Article Title: Identification of a Twelve-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival for Medulloblastoma
    Article Snippet: .. The prognostic genes expression in the gene signature was further validated by using The Oncomine database , TIMER database ( ) and The Human Protein Atlas database . cBioportal for Cancer Genomics was explored to investigate the genetic alterations of the prognostic genes in the gene signature. ..

    Article Title: USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma
    Article Snippet: .. The relationship between USP35 RNA sequences and clinical profiles in TCGA was visualized through the MEXPRESS database ( https://mexpress.be/index.html ), Tumor Immune Estimation Resource (TIMER, https://cistrome.shinyapps.io/timer/ ) and Human Protein Atlas (HPA, https://www.proteinatlas.org/ ) were conducted to examine USP35 expression at the mRNA and protein levels, respectively, and GEO data including GSE15605 and GSE114445 were used to validate the differential expression results. ..

    Article Title: Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer
    Article Snippet: .. The Human Protein Atlas (HPA) database was used to detect the expression of FAM110A in human normal tissues, the Tumor Immune Estimation Resource (TIMER) and TIMER 2.0 databases were used to explore the association of FAM110A expression with immune checkpoint genes and immune infiltration, and the Gene Set Cancer Analysis (GSCA) database was used to explore the correlation between FAM110A expression and copy number variations (CNV) and methylation. ..

    Quantitative Proteomics:

    Article Title: USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma
    Article Snippet: .. The relationship between USP35 RNA sequences and clinical profiles in TCGA was visualized through the MEXPRESS database ( https://mexpress.be/index.html ), Tumor Immune Estimation Resource (TIMER, https://cistrome.shinyapps.io/timer/ ) and Human Protein Atlas (HPA, https://www.proteinatlas.org/ ) were conducted to examine USP35 expression at the mRNA and protein levels, respectively, and GEO data including GSE15605 and GSE114445 were used to validate the differential expression results. ..

    Methylation:

    Article Title: Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer
    Article Snippet: .. The Human Protein Atlas (HPA) database was used to detect the expression of FAM110A in human normal tissues, the Tumor Immune Estimation Resource (TIMER) and TIMER 2.0 databases were used to explore the association of FAM110A expression with immune checkpoint genes and immune infiltration, and the Gene Set Cancer Analysis (GSCA) database was used to explore the correlation between FAM110A expression and copy number variations (CNV) and methylation. ..



    Similar Products

    waring 3 speed 4-liter blender with timer  (Eberbach Corporation)
    93
    Eberbach Corporation waring 3 speed 4-liter blender with timer
    Waring 3 Speed 4 Liter Blender With Timer, supplied by Eberbach Corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/timer/Waring+3+Speed+4-Liter+Blender+with+Timer/custom%40e8000%2Etb%4042402226
    Average 93 stars, based on 1 article reviews
    waring 3 speed 4-liter blender with timer - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    timer video tracking software  (Noldus Information Technology)
    86
    Noldus Information Technology timer video tracking software
    Timer Video Tracking Software, supplied by Noldus Information Technology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/timer/software+timer+tracking+video/pm42307079-459-102-108
    Average 86 stars, based on 1 article reviews
    timer video tracking software - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    555 timer  (Texas Instruments)
    86
    Texas Instruments 555 timer
    555 Timer, supplied by Texas Instruments, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/timer/555+timer/us12656238-214-13-16
    Average 86 stars, based on 1 article reviews
    555 timer - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    yb 1a reaction timer  (Takei Co Ltd)
    86
    Takei Co Ltd yb 1a reaction timer
    Yb 1a Reaction Timer, supplied by Takei Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/timer/1a+reaction+timer+yb/pm42280328-124-7-10
    Average 86 stars, based on 1 article reviews
    yb 1a reaction timer - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    timer  (Analab Inc)
    86
    Analab Inc timer
    Timer, supplied by Analab Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/timer/timer/pmc13208825-167-20-26
    Average 86 stars, based on 1 article reviews
    timer - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    timer 2 0  (Human Protein Atlas)
    86
    Human Protein Atlas timer 2 0
    The expression of USP22 in various malignancies and the corresponding normal tissues was obtained using Timer 2.0. ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; COAD, colon adenocarcinoma; DLBC, lymphoid neoplasm diffuse large B‐cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LAML, acute myeloid leukemia; LGG, brain lower grade glioma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumors; THCA, thyroid carcinoma; THYM, thymoma; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma. The number of stars represents the statistical significance as determined by the Wilcoxon test (** p < 0.01, and *** p < 0.001).
    Timer 2 0, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/timer/0+2+timer/pmc13171463-30-6-1
    Average 86 stars, based on 1 article reviews
    timer 2 0 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    lmc555 cmos low power timer  (Texas Instruments)
    86
    Texas Instruments lmc555 cmos low power timer
    The expression of USP22 in various malignancies and the corresponding normal tissues was obtained using Timer 2.0. ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; COAD, colon adenocarcinoma; DLBC, lymphoid neoplasm diffuse large B‐cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LAML, acute myeloid leukemia; LGG, brain lower grade glioma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumors; THCA, thyroid carcinoma; THYM, thymoma; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma. The number of stars represents the statistical significance as determined by the Wilcoxon test (** p < 0.01, and *** p < 0.001).
    Lmc555 Cmos Low Power Timer, supplied by Texas Instruments, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/timer/555+timer/us12622695-187-8-14
    Average 86 stars, based on 1 article reviews
    lmc555 cmos low power timer - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    tandem fluorescent protein timer recombination insertion construct  (Synbio Tech Inc)
    86
    Synbio Tech Inc tandem fluorescent protein timer recombination insertion construct
    The expression of USP22 in various malignancies and the corresponding normal tissues was obtained using Timer 2.0. ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; COAD, colon adenocarcinoma; DLBC, lymphoid neoplasm diffuse large B‐cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LAML, acute myeloid leukemia; LGG, brain lower grade glioma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumors; THCA, thyroid carcinoma; THYM, thymoma; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma. The number of stars represents the statistical significance as determined by the Wilcoxon test (** p < 0.01, and *** p < 0.001).
    Tandem Fluorescent Protein Timer Recombination Insertion Construct, supplied by Synbio Tech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/timer/construct+fluorescent+insertion+protein+recombination+tandem+timer/bio_rxiv__64898__2026__05__06__723156-150-1-11
    Average 86 stars, based on 1 article reviews
    tandem fluorescent protein timer recombination insertion construct - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    The expression of USP22 in various malignancies and the corresponding normal tissues was obtained using Timer 2.0. ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; COAD, colon adenocarcinoma; DLBC, lymphoid neoplasm diffuse large B‐cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LAML, acute myeloid leukemia; LGG, brain lower grade glioma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumors; THCA, thyroid carcinoma; THYM, thymoma; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma. The number of stars represents the statistical significance as determined by the Wilcoxon test (** p < 0.01, and *** p < 0.001).

    Journal: Cancer Reports

    Article Title: Decoding the Oncogenic Role of USP22 Through Pan‐Cancer Genomic and Epigenetic Analysis

    doi: 10.1002/cnr2.70572

    Figure Lengend Snippet: The expression of USP22 in various malignancies and the corresponding normal tissues was obtained using Timer 2.0. ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; COAD, colon adenocarcinoma; DLBC, lymphoid neoplasm diffuse large B‐cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LAML, acute myeloid leukemia; LGG, brain lower grade glioma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumors; THCA, thyroid carcinoma; THYM, thymoma; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma. The number of stars represents the statistical significance as determined by the Wilcoxon test (** p < 0.01, and *** p < 0.001).

    Article Snippet: The Human Protein Atlas, UALCAN, and Timer 2.0 were used to examine USP22 expression at the gene and protein levels in 33 TCGA cancer types.

    Techniques: Expressing